Research ArticleCancer

Amplification of the Driving Oncogene, KRAS or BRAF, Underpins Acquired Resistance to MEK1/2 Inhibitors in Colorectal Cancer Cells

See allHide authors and affiliations

Science Signaling  29 Mar 2011:
Vol. 4, Issue 166, pp. ra17
DOI: 10.1126/scisignal.2001752

Log in to view PDF

Log in through your institution

Log in through your institution